Länder Analysen: Großbritannien
| 18.02.25 | Unilever Outperform | Bernstein Research | |
| 18.02.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 17.02.25 | BAT Buy | Deutsche Bank AG | |
| 17.02.25 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.02.25 | Unilever Buy | Deutsche Bank AG | |
| 14.02.25 | RELX Buy | UBS AG | |
| 14.02.25 | RELX Outperform | Bernstein Research | |
| 13.02.25 | BAT Buy | UBS AG | |
|
Werbung
|
|||
| 13.02.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | Unilever Outperform | Bernstein Research | |
| 13.02.25 | BAT Buy | UBS AG | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 12.02.25 | National Grid Overweight | JP Morgan Chase & Co. | |
| 12.02.25 | BP Buy | UBS AG | |
| 12.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | BP Buy | Jefferies & Company Inc. | |
| 11.02.25 | BP Buy | UBS AG | |
| 11.02.25 | RELX Outperform | Bernstein Research | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 11.02.25 | easyJet Overweight | JP Morgan Chase & Co. | |
| 10.02.25 | Linde Kaufen | DZ BANK | |
| 10.02.25 | BAT Buy | UBS AG | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Linde Outperform | Bernstein Research | |
| 10.02.25 | BP Buy | Jefferies & Company Inc. | |
| 10.02.25 | BP Buy | Jefferies & Company Inc. | |
| 07.02.25 | GSK Outperform | Bernstein Research | |
| 06.02.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 06.02.25 | BAT Buy | UBS AG | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Diageo Outperform | Bernstein Research | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | Diageo Buy | UBS AG | |
| 05.02.25 | Unilever Outperform | Bernstein Research | |
| 05.02.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | Linde Outperform | Bernstein Research | |
| 04.02.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 04.02.25 | Diageo Buy | UBS AG | |
| 03.02.25 | Diageo Buy | Jefferies & Company Inc. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Reckitt Benckiser Buy | UBS AG | |
| 03.02.25 | HSBC Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |